Form D · Pharmaceuticals
Maia Pharmaceuticals, Inc.
Princeton, NJ · CIK 0001624757
Offering snapshot reported Nov 12, 2014 · SEC filing
- Reported sold
- $845K Offering amount: $1.57M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 29, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 12, 2014 | Initial | $845,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-228154
Source: Form D, filed Nov 12, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Vishnukant Bhutada | Director |
| Brian Lipton | Director |
| Srikanth Sundaram | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
707 State Road, Suite 104
Princeton, NJ, 08540
Princeton, NJ, 08540